Last Updated: June 1, 2026

Drug Price Trends for FT CALAMINE LOTION


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for FT CALAMINE LOTION

Average Pharmacy Cost for FT CALAMINE LOTION

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
FT CALAMINE LOTION 70677-1196-01 0.01035 ML 2026-05-20
FT CALAMINE LOTION 70677-1196-01 0.00997 ML 2026-04-22
FT CALAMINE LOTION 70677-1196-01 0.01043 ML 2026-03-18
FT CALAMINE LOTION 70677-1196-01 0.01068 ML 2026-02-18
FT CALAMINE LOTION 70677-1196-01 0.01055 ML 2026-01-21
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for FT Calamine Lotion

Last updated: February 19, 2026

What is the Current Market Environment for Calamine Lotion?

Calamine lotion remains a widely used OTC topical treatment for mild skin irritations such as insect bites, sunburns, and poison ivy. The global dermatology market, valued at USD 23.4 billion in 2022, grows annually at approximately 4.8% (CAGR), with OTC products comprising roughly 65% of the segment [1]. Calamine lotion holds a stable but niche position within this market.

Key drivers include:

  • Skin irritation prevalence.
  • Consumer preference for OTC, minimally invasive remedies.
  • Increasing awareness of dermatological health.

Major competitors include Johnson & Johnson, Bayer, and local OTC brands, with several generic versions available.

Patent Status and Regulatory Landscape

FT Calamine Lotion is marketed as an OTC product, with no recent patent protections, allowing multiple manufacturers to produce similar formulations. The last patent filings globally expired around 2010, leading to a saturated market with multiple brands offering comparable products.

Regulatory oversight primarily from the U.S. FDA, European EMA, and corresponding agencies in emerging markets. The product classification as a traditional OTC OTC substance limits the need for complex regulatory hurdles but enforces adherence to safety and labeling standards.

Market Size and Distribution Channels

  • Estimated global market size for calamine lotion is approximately USD 150 million in 2022.
  • North America and Europe comprise about 60% of this market.
  • Asia-Pacific shows the highest growth potential, with a CAGR of approximately 6%, driven by increasing rural populations and rising dermatology awareness.
  • Distribution occurs through pharmacy chains, online retail, and mass-market outlets.

Pricing Analysis

  • Average retail price per 4 oz (118 mL) bottle ranges from USD 3.50 to USD 5.50 in North America.
  • Generic brands typically price around USD 3.50–4.50.
  • Brand-name products like Caladryl or equivalent command USD 5.00–5.50.
  • Discounting strategies are prevalent in online channels, often offering 10–15% off.

Price Projection Assumptions

Future pricing depends on regulatory changes, raw material costs, brand positioning, and market competition. Based on current trends:

  • Raw material costs projected to decrease by 2% annually due to increased manufacturing efficiencies.
  • Brand differentiation will decline as more generics enter markets.
  • Margins are expected to compressed, with current gross profit margins approximately 35–40%.

Considering these factors, the average retail price for a 4 oz bottle is projected to decline gradually:

Year Estimated Average Price (USD) Change from Previous Year
2023 4.50 N/A
2024 4.45 -1.1%
2025 4.40 -1.1%
2026 4.35 -1.1%

The price decline stabilizes as market share stabilizes and brand differentiation diminishes.

Revenue and Market Share Projections

Assuming a steady market size of USD 150 million:

  • The share of FT Calamine Lotion depends on brand strength.
  • If FT holds a 10% market share by 2025, annual revenue projections:
Year Market Share Revenue (USD million)
2023 8% 12
2024 9% 13.5
2025 10% 15

Growth prospects depend on product promotion, geographical expansion, and formulation innovation.

Key Market Risks and Opportunities

Risks:

  • Commoditization leading to margin erosion.
  • Regulatory changes impacting OTC drug classifications.
  • Competition from natural or alternative remedies.

Opportunities:

  • Expanding into emerging markets.
  • Developing medicated formulations with added benefits.
  • Online retail channels lowering distribution costs.

Final Observations

The market for calamine lotion is mature with limited growth but stable demand. Price declines are anticipated due to generic competition and market saturation. Revenue growth hinges on expanding geographic reach and brand recognition. Investment in product differentiation and market expansion could offset downward pricing pressures.


Key Takeaways

  • The global calamine lotion market is approximately USD 150 million, with growth driven by emerging markets.
  • Prices are declining slightly, with an average of USD 4.50 per 4 oz bottle in 2023.
  • Market share projections suggest modest revenue increases, assuming growth strategies are executed.
  • Competition from generics influences pricing and margins.
  • Opportunities exist in global expansion and product innovation.

FAQs

1. What factors influence the price of FT Calamine Lotion?
Raw material costs, market competition, regulatory changes, and brand positioning.

2. How saturated is the calamine lotion market?
Highly saturated with multiple generic players; patent protections expired over a decade ago.

3. What growth opportunities exist for calamine lotion?
Expansion into emerging markets and formulation innovations.

4. How do online sales impact pricing strategies?
Online channels often drive price discounts of 10–15%, exerting downward pressure.

5. Will regulatory changes significantly affect the market?
Limited impact currently; future changes could influence OTC classification or labeling requirements.


References

[1] Grand View Research. (2022). Dermatology Market Size, Share & Trends Analysis. https://www.grandviewresearch.com/industry-analysis/dermatology-market

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.